[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware
(State or other jurisdiction of
incorporation or organization) |
51-0263969
(I.R.S. Employer Identification No.)
|
6901 Professional Pkwy. East, Suite 200
Sarasota, Florida (Address of principal executive offices) |
34240
(Zip Code)
|
(941) 556-2601
(Registrant's telephone number, including area code)
|
þ Large accelerated filer
|
¨ Accelerated filer
|
¨ Non-accelerated filer
(do not check if smaller reporting company)
|
¨ Smaller reporting company
|
|
|
Page
|
PART I.
|
FINANCIAL INFORMATION
|
|
Item 1.
|
Financial Statements (unaudited):
|
|
|
Condensed Consolidated Statements of Earnings
|
3
|
|
Condensed Consolidated Statements of Comprehensive Income
|
4
|
|
Condensed Consolidated Balance Sheets
|
5
|
|
Condensed Consolidated Statements of Cash Flows
|
6
|
|
Condensed Consolidated Statement of Changes in Stockholders' Equity
|
7
|
|
Notes to Condensed Consolidated Financial Statements
|
8
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
15
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
22
|
Item 4.
|
Controls and Procedures
|
22
|
PART II.
|
OTHER INFORMATION
|
|
Item 1.
|
Legal Proceedings
|
23
|
Item 1A.
|
Risk Factors
|
23
|
Item 6.
|
Exhibits
|
23
|
|
Signatures
|
24
|
PART I. | FINANCIAL INFORMATION |
|
|
Three months ended September 30,
|
|
Nine months ended September 30,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
827,810
|
|
$
|
747,641
|
|
$
|
2,348,955
|
|
$
|
2,183,579
|
|
Cost of sales
|
|
|
345,185
|
|
|
331,086
|
|
|
999,247
|
|
|
978,223
|
|
Gross profit
|
|
|
482,625
|
|
|
416,555
|
|
|
1,349,708
|
|
|
1,205,356
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
263,276
|
|
|
233,298
|
|
|
765,436
|
|
|
673,011
|
|
Income from operations
|
|
|
219,349
|
|
|
183,257
|
|
|
584,272
|
|
|
532,345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
24,705
|
|
|
16,456
|
|
|
67,924
|
|
|
47,016
|
|
Loss on extinguishment of debt
|
|
|
-
|
|
|
1,043
|
|
|
-
|
|
|
1,043
|
|
Other income/(expense), net
|
|
|
409
|
|
|
(1,380
|
)
|
|
453
|
|
|
(2,444
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings before income taxes
|
|
|
195,053
|
|
|
164,378
|
|
|
516,801
|
|
|
481,842
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
|
58,730
|
|
|
47,670
|
|
|
144,211
|
|
|
142,012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
136,323
|
|
$
|
116,708
|
|
$
|
372,590
|
|
$
|
339,830
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.37
|
|
$
|
1.19
|
|
$
|
3.76
|
|
$
|
3.49
|
|
Diluted
|
|
|
1.36
|
|
|
1.17
|
|
|
3.72
|
|
|
3.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
99,207
|
|
|
97,876
|
|
|
99,058
|
|
|
97,460
|
|
Diluted
|
|
|
100,302
|
|
|
99,757
|
|
|
100,152
|
|
|
99,543
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.1650
|
|
$
|
0.1375
|
|
$
|
0.4950
|
|
$
|
0.4125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
September 30,
|
|
Nine months ended September 30,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
136,323
|
|
$
|
116,708
|
|
$
|
372,590
|
|
$
|
339,830
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income/(loss), net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
|
|
31,902
|
|
|
36,395
|
|
|
(10,219
|
)
|
|
22,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income/(loss), net of tax
|
|
|
31,902
|
|
|
36,395
|
|
|
(10,219
|
)
|
|
22,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
168,225
|
|
$
|
153,103
|
|
$
|
362,371
|
|
$
|
362,178
|
|
|
|
September 30,
2013 |
|
December 31,
2012 |
|
|||
ASSETS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
459,980
|
|
$
|
370,590
|
|
|
Accounts receivable, net
|
|
|
505,284
|
|
|
526,408
|
|
|
Inventories, net
|
|
|
204,722
|
|
|
190,867
|
|
|
Deferred taxes
|
|
|
88,421
|
|
|
41,992
|
|
|
Unbilled receivables
|
|
|
85,375
|
|
|
72,193
|
|
|
Other current assets
|
|
|
45,417
|
|
|
43,492
|
|
|
Total current assets
|
|
|
1,389,199
|
|
|
1,245,542
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
117,785
|
|
|
110,397
|
|
|
Goodwill
|
|
|
4,541,772
|
|
|
3,868,857
|
|
|
Other intangible assets, net
|
|
|
2,051,685
|
|
|
1,698,867
|
|
|
Deferred taxes
|
|
|
68,048
|
|
|
78,644
|
|
|
Other assets
|
|
|
77,086
|
|
|
68,797
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
8,245,575
|
|
$
|
7,071,104
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
142,987
|
|
$
|
138,340
|
|
|
Accrued compensation
|
|
|
100,901
|
|
|
110,724
|
|
|
Deferred revenue
|
|
|
212,275
|
|
|
185,912
|
|
|
Other accrued liabilities
|
|
|
153,293
|
|
|
128,351
|
|
|
Deferred taxes
|
|
|
12,431
|
|
|
3,868
|
|
|
Current portion of long-term debt, net
|
|
|
12,250
|
|
|
519,015
|
|
|
Total current liabilities
|
|
|
634,137
|
|
|
1,086,210
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt, net of current portion
|
|
|
2,593,607
|
|
|
1,503,107
|
|
|
Deferred taxes
|
|
|
862,986
|
|
|
707,278
|
|
|
Other liabilities
|
|
|
92,032
|
|
|
86,783
|
|
|
Total liabilities
|
|
|
4,182,762
|
|
|
3,383,378
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 10)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
1,013
|
|
|
1,006
|
|
|
Additional paid-in capital
|
|
|
1,219,648
|
|
|
1,158,001
|
|
|
Retained earnings
|
|
|
2,813,356
|
|
|
2,489,858
|
|
|
Accumulated other comprehensive earnings
|
|
|
48,318
|
|
|
58,537
|
|
|
Treasury stock
|
|
|
(19,522
|
)
|
|
(19,676
|
)
|
|
Total stockholders' equity
|
|
|
4,062,813
|
|
|
3,687,726
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
8,245,575
|
|
$
|
7,071,104
|
|
|
|
Nine months ended September 30,
|
|
||||
|
|
2013
|
|
2012
|
|
||
Cash flows from operating activities:
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
372,590
|
|
$
|
339,830
|
|
Adjustments to reconcile net earnings to cash flows from operating activities:
|
|
|
|
|
|
|
|
Depreciation and amortization of property, plant and equipment
|
|
|
28,269
|
|
|
28,402
|
|
Amortization of intangible assets
|
|
|
111,210
|
|
|
82,398
|
|
Amortization of deferred financing costs
|
|
|
2,916
|
|
|
1,750
|
|
Non-cash stock compensation
|
|
|
40,040
|
|
|
30,143
|
|
Changes in operating assets and liabilities, net of acquired businesses:
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
43,101
|
|
|
6,685
|
|
Unbilled receivables
|
|
|
(13,257
|
)
|
|
(2,698
|
)
|
Inventories
|
|
|
(15,202
|
)
|
|
(2,985
|
)
|
Accounts payable and accrued liabilities
|
|
|
13,055
|
|
|
(8,617
|
)
|
Income taxes
|
|
|
(12,643
|
)
|
|
(14,258
|
)
|
Other, net
|
|
|
(3,306
|
)
|
|
5,564
|
|
Cash provided by operating activities
|
|
|
566,773
|
|
|
466,214
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
Acquisitions of businesses, net of cash acquired
|
|
|
(1,014,952
|
)
|
|
(1,445,549
|
)
|
Capital expenditures
|
|
|
(33,349
|
)
|
|
(29,236
|
)
|
Proceeds from sale of assets
|
|
|
1,740
|
|
|
1,196
|
|
Other, net
|
|
|
(144
|
)
|
|
(542
|
)
|
Cash used in investing activities
|
|
|
(1,046,705
|
)
|
|
(1,474,131
|
)
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
Proceeds from senior notes
|
|
|
800,000
|
|
|
-
|
|
Payment of senior notes
|
|
|
(500,000
|
)
|
|
-
|
|
Borrowings/(payments) under revolving line of credit, net
|
|
|
290,000
|
|
|
1,050,000
|
|
Principal payments on convertible notes
|
|
|
(2,115
|
)
|
|
(26,826
|
)
|
Cash premiums paid on convertible note conversions
|
|
|
(5,100
|
)
|
|
(19,149
|
)
|
Debt issuance costs
|
|
|
(7,717
|
)
|
|
(4,551
|
)
|
Cash dividends to stockholders
|
|
|
(32,706
|
)
|
|
(40,102
|
)
|
Proceeds from stock based compensation, net
|
|
|
16,839
|
|
|
40,105
|
|
Stock award tax excess windfall benefit
|
|
|
7,763
|
|
|
19,873
|
|
Treasury stock sales
|
|
|
1,833
|
|
|
1,623
|
|
Other
|
|
|
723
|
|
|
(979
|
)
|
Cash provided by financing activities
|
|
|
569,520
|
|
|
1,019,994
|
|
|
|
|
|
|
|
|
|
Effect of foreign currency exchange rate changes on cash
|
|
|
(198
|
)
|
|
4,931
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
89,390
|
|
|
17,008
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
|
|
370,590
|
|
|
338,101
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period
|
|
$
|
459,980
|
|
$
|
355,109
|
|
|
|
Common
stock |
|
Additional paid-in capital
|
|
Retained
earnings
|
|
Accumulated other comprehensive earnings
|
|
Treasury
stock
|
|
Total
|
|
||||||
Balances at December 31, 2012
|
|
$
|
1,006
|
|
$
|
1,158,001
|
|
$
|
2,489,858
|
|
$
|
58,537
|
|
$
|
(19,676
|
)
|
$
|
3,687,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
|
-
|
|
|
-
|
|
|
372,590
|
|
|
-
|
|
|
-
|
|
|
372,590
|
|
Stock option exercises
|
|
|
4
|
|
|
20,446
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
20,450
|
|
Treasury stock sold
|
|
|
-
|
|
|
1,679
|
|
|
-
|
|
|
-
|
|
|
154
|
|
|
1,833
|
|
Currency translation adjustments, net of $889 tax
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(10,219
|
)
|
|
-
|
|
|
(10,219
|
)
|
Stock based compensation
|
|
|
-
|
|
|
40,201
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
40,201
|
|
Restricted stock activity
|
|
|
3
|
|
|
(3,598
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(3,595
|
)
|
Stock option tax benefit, net of shortfalls
|
|
|
-
|
|
|
7,632
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
7,632
|
|
Conversion of senior subordinated convertible notes,
net of $386 tax
|
|
|
|
|
|
(4,713
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(4,713
|
)
|
Dividends declared
|
|
|
-
|
|
|
-
|
|
|
(49,092
|
)
|
|
-
|
|
|
-
|
|
|
(49,092
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at September 30, 2013
|
|
$
|
1,013
|
|
$
|
1,219,648
|
|
$
|
2,813,356
|
|
$
|
48,318
|
|
$
|
(19,522
|
)
|
$
|
4,062,813
|
|
1.
|
Basis of Presentation
|
2.
|
Recent Accounting Pronouncements
|
3.
|
Earnings Per Share
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
Basic shares outstanding
|
99,207
|
97,876
|
99,058
|
97,460
|
||||||||||||
Effect of potential common stock:
|
||||||||||||||||
Common stock awards
|
905
|
1,017
|
894
|
1,077
|
||||||||||||
Senior subordinated convertible notes
|
190
|
864
|
200
|
1,006
|
||||||||||||
Diluted shares outstanding
|
100,302
|
99,757
|
100,152
|
99,543
|
4.
|
Business Acquisitions
|
Current assets
|
$ 59,813
|
|
Identifiable intangibles
|
465,500
|
|
Goodwill
|
680,732
|
|
Other assets
|
5,798
|
|
Total assets acquired
|
1,211,843
|
|
Current liabilities
|
(24,717
|
)
|
Long-term deferred tax liability
|
(165,052
|
)
|
Other liabilities
|
(6,524
|
)
|
Net assets acquired
|
$ 1,015,550
|
|
|
Three months ended
September 30, 2012 |
Nine months ended
September 30, 2012 |
||||||
Sales
|
$
|
780,278
|
$
|
2,320,497
|
||||
Net income
|
128,226
|
380,046
|
||||||
Earnings per share, basic
|
1.31
|
3.90
|
||||||
Earnings per share, diluted
|
1.29
|
3.82
|
5.
|
Stock Based Compensation
|
|
Three months ended September 30,
|
Nine months ended
September 30, |
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
Stock based compensation
|
$
|
13,756
|
$
|
10,439
|
$
|
40,040
|
$
|
30,143
|
||||||||
Tax effect recognized in net income
|
4,814
|
3,654
|
14,014
|
10,550
|
||||||||||||
Windfall tax benefit, net
|
2,075
|
9,009
|
7,632
|
19,975
|
|
Nine months ended September 30,
|
||
|
2013
|
|
2012
|
Fair value per share ($)
|
36.87
|
|
30.19
|
Risk-free interest rate (%)
|
0.80
|
|
0.77
|
Expected option life (years)
|
5.19
|
|
5.24
|
Expected volatility (%)
|
36.20
|
|
36.51
|
Expected dividend yield (%)
|
0.57
|
|
0.58
|
6.
|
Inventories
|
|
|
September 30,
2013 |
|
December 31,
2012 |
|
||
Raw materials and supplies
|
|
$
|
128,809
|
|
$
|
121,573
|
|
Work in process
|
|
|
33,133
|
|
|
29,725
|
|
Finished products
|
|
|
88,614
|
|
|
81,536
|
|
Inventory reserves
|
|
|
(45,834
|
)
|
|
(41,967
|
)
|
|
|
$
|
204,722
|
|
$
|
190,867
|
|
7.
|
Goodwill and Other Intangible Assets
|
|
|
Industrial Technology
|
|
Energy Systems & Controls
|
|
Medical & Scientific
Imaging |
|
RF
Technology |
|
Total
|
|
|||||
Balances at December 31, 2012
|
|
$
|
421,755
|
|
$
|
404,057
|
|
$
|
1,772,402
|
|
$
|
1,270,643
|
|
$
|
3,868,857
|
|
Additions
|
|
|
-
|
|
|
-
|
|
|
680,732
|
|
|
-
|
|
|
680,732
|
|
Other
|
|
|
-
|
|
|
2,660
|
|
|
(4,283
|
)
|
|
445
|
|
|
(1,178
|
)
|
Currency translation adjustments
|
|
|
1,929
|
|
|
(215
|
)
|
|
(7,084
|
)
|
|
(1,269
|
)
|
|
(6,639
|
)
|
Balances at September 30, 2013
|
|
$
|
423,684
|
|
$
|
406,502
|
|
$
|
2,441,767
|
|
$
|
1,269,819
|
|
$
|
4,541,772
|
|
|
|
Cost
|
|
Accumulated
amortization |
|
Net book
value |
|
|||
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Customer related intangibles
|
|
$
|
1,509,339
|
|
$
|
(379,535
|
)
|
$
|
1,129,804
|
|
Unpatented technology
|
|
|
198,609
|
|
|
(97,487
|
)
|
|
101,122
|
|
Software
|
|
|
160,520
|
|
|
(44,256
|
)
|
|
116,264
|
|
Patents and other protective rights
|
|
|
40,399
|
|
|
(20,312
|
)
|
|
20,087
|
|
Trade secrets
|
|
|
1,500
|
|
|
(1,500
|
)
|
|
-
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
331,590
|
|
|
-
|
|
|
331,590
|
|
Balances at December 31, 2012
|
|
$
|
2,241,957
|
|
$
|
(543,090
|
)
|
$
|
1,698,867
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Customer related intangibles
|
|
$
|
1,939,270
|
|
$
|
(456,068
|
)
|
$
|
1,483,202
|
|
Unpatented technology
|
|
|
212,049
|
|
|
(116,355
|
)
|
|
95,694
|
|
Software
|
|
|
160,496
|
|
|
(54,777
|
)
|
|
105,719
|
|
Patents and other protective rights
|
|
|
30,390
|
|
|
(22,017
|
)
|
|
8,373
|
|
Trade secrets
|
|
|
1,500
|
|
|
(1,500
|
)
|
|
-
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
358,697
|
|
|
-
|
|
|
358,697
|
|
Balances at September 30, 2013
|
|
$
|
2,702,402
|
|
$
|
(650,717
|
)
|
$
|
2,051,685
|
|
8.
|
Debt
|
9.
|
Fair Value of Financial Instruments
|
$400 million senior notes due 2017
|
$ 398
|
$800 million senior notes due 2018
|
786
|
$500 million senior notes due 2019
|
583
|
$500 million senior notes due 2022
|
468
|
10.
|
Contingencies
|
Balance at December 31, 2012
|
|
$
|
9,755
|
|
Additions charged to costs and expenses*
|
|
|
17,659
|
|
Deductions
|
|
|
(11,251
|
)
|
Other
|
|
|
(168)
|
|
Balance at September 30, 2013
|
|
$
|
15,995
|
|
11.
|
Business Segments
|
|
Three months ended
September 30, |
|
|
Nine months ended
September 30, |
|
|
||||||||
|
2013
|
|
2012
|
Change
|
|
2013
|
|
2012
|
Change
|
|
||||
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
200,684
|
|
$
|
199,008
|
0.8
|
%
|
$
|
580,466
|
|
$
|
598,088
|
(2.9
|
)%
|
Energy Systems & Controls
|
|
155,058
|
|
|
158,169
|
(2.0
|
)
|
|
456,031
|
|
|
461,508
|
(1.2
|
)
|
Medical & Scientific Imaging
|
|
237,338
|
|
|
172,475
|
37.6
|
|
|
645,739
|
|
|
486,207
|
32.8
|
|
RF Technology
|
|
234,730
|
|
|
217,989
|
7.7
|
|
|
666,719
|
|
|
637,776
|
4.5
|
|
Total
|
$
|
827,810
|
|
$
|
747,641
|
10.7
|
%
|
$
|
2,348,955
|
|
$
|
2,183,579
|
7.6
|
%
|
Gross profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
101,259
|
|
$
|
102,569
|
(1.3
|
)%
|
$
|
296,414
|
|
$
|
304,002
|
(2.5
|
)%
|
Energy Systems & Controls
|
|
88,104
|
|
|
87,782
|
0.4
|
|
|
256,431
|
|
|
254,325
|
0.8
|
|
Medical & Scientific Imaging
|
|
167,433
|
|
|
112,013
|
49.5
|
|
|
440,718
|
|
|
314,411
|
40.2
|
|
RF Technology
|
|
125,829
|
|
|
114,191
|
10.2
|
|
|
356,145
|
|
|
332,618
|
7.1
|
|
Total
|
$
|
482,625
|
|
$
|
416,555
|
15.9
|
%
|
$
|
1,349,708
|
|
$
|
1,205,356
|
12.0
|
%
|
Operating profit*:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
60,753
|
|
$
|
60,628
|
0.2
|
%
|
$
|
164,278
|
|
$
|
180,211
|
(8.8
|
)%
|
Energy Systems & Controls
|
|
41,076
|
|
|
42,890
|
(4.2
|
)
|
|
118,432
|
|
|
118,749
|
(0.3
|
)
|
Medical & Scientific Imaging
|
|
71,968
|
|
|
46,190
|
55.8
|
|
|
179,433
|
|
|
125,231
|
43.3
|
|
RF Technology
|
|
66,469
|
|
|
58,002
|
14.6
|
|
|
183,828
|
|
|
166,516
|
10.4
|
|
Total
|
$
|
240,266
|
|
$
|
207,710
|
15.7
|
%
|
$
|
645,971
|
|
$
|
590,707
|
9.4
|
%
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
49,055
|
|
$
|
42,970
|
|
|
|
|
|
|
|
|
|
Energy Systems & Controls
|
|
19,501
|
|
|
19,016
|
|
|
|
|
|
|
|
|
|
Medical & Scientific Imaging
|
|
43,105
|
|
|
44,784
|
|
|
|
|
|
|
|
|
|
RF Technology
|
|
28,360
|
|
|
29,230
|
|
|
|
|
|
|
|
|
|
Total
|
$
|
140,021
|
|
$
|
136,000
|
|
|
|
|
|
|
|
|
|
·
|
general economic conditions;
|
·
|
difficulty making acquisitions and successfully integrating acquired businesses;
|
·
|
any unforeseen liabilities associated with future acquisitions;
|
·
|
limitations on our business imposed by our indebtedness;
|
·
|
unfavorable changes in foreign exchange rates;
|
·
|
difficulties associated with exports;
|
·
|
risks and costs associated with our international sales and operations;
|
·
|
increased directors' and officers' liability and other insurance costs;
|
·
|
risk of rising interest rates;
|
·
|
product liability and insurance risks;
|
·
|
increased warranty exposure;
|
·
|
future competition;
|
·
|
the cyclical nature of some of our markets;
|
·
|
reduction of business with large customers;
|
·
|
risks associated with government contracts;
|
·
|
changes in the supply of, or price for, raw materials, parts and components;
|
·
|
environmental compliance costs and liabilities;
|
·
|
risks and costs associated with asbestos-related litigation;
|
·
|
potential write-offs of our substantial goodwill and other intangible assets;
|
·
|
our ability to successfully develop new products;
|
·
|
failure to protect our intellectual property;
|
·
|
the effect of, or change in, government regulations (including tax);
|
·
|
economic disruption caused by terrorist attacks, health crises or other unforeseen events; and
|
·
|
the factors discussed in other reports filed with the SEC.
|
|
|
Three months ended
September 30, |
|
Nine months ended
September 30, |
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
200,684
|
|
$
|
199,008
|
|
$
|
580,466
|
|
$
|
598,088
|
|
Energy Systems & Controls
|
|
|
155,058
|
|
|
158,169
|
|
|
456,031
|
|
|
461,508
|
|
Medical & Scientific Imaging
|
|
|
237,338
|
|
|
172,475
|
|
|
645,739
|
|
|
486,207
|
|
RF Technology
|
|
|
234,730
|
|
|
217,989
|
|
|
666,719
|
|
|
637,776
|
|
Total
|
|
$
|
827,810
|
|
$
|
747,641
|
|
$
|
2,348,955
|
|
$
|
2,183,579
|
|
Gross profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
50.5
|
%
|
|
51.5
|
%
|
|
51.1
|
%
|
|
50.8
|
%
|
Energy Systems & Controls
|
|
|
56.8
|
|
|
55.5
|
|
|
56.2
|
|
|
55.1
|
|
Medical & Scientific Imaging
|
|
|
70.5
|
|
|
64.9
|
|
|
68.3
|
|
|
64.7
|
|
RF Technology
|
|
|
53.6
|
|
|
52.4
|
|
|
53.4
|
|
|
52.2
|
|
Total
|
|
|
58.3
|
|
|
55.7
|
|
|
57.5
|
|
|
55.2
|
|
Selling, general & administrative expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
20.2
|
%
|
|
21.1
|
%
|
|
22.8
|
%
|
|
20.7
|
%
|
Energy Systems & Controls
|
|
|
30.3
|
|
|
28.4
|
|
|
30.3
|
|
|
29.4
|
|
Medical & Scientific Imaging
|
|
|
40.2
|
|
|
38.2
|
|
|
40.5
|
|
|
38.9
|
|
RF Technology
|
|
|
25.3
|
|
|
25.8
|
|
|
25.8
|
|
|
26.0
|
|
Total
|
|
|
29.3
|
|
|
27.9
|
|
|
30.0
|
|
|
28.1
|
|
Segment operating profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
30.3
|
%
|
|
30.5
|
%
|
|
28.3
|
%
|
|
30.1
|
%
|
Energy Systems & Controls
|
|
|
26.5
|
|
|
27.1
|
|
|
26.0
|
|
|
25.7
|
|
Medical & Scientific Imaging
|
|
|
30.3
|
|
|
26.8
|
|
|
27.8
|
|
|
25.8
|
|
RF Technology
|
|
|
28.3
|
|
|
26.6
|
|
|
27.6
|
|
|
26.1
|
|
Total
|
|
|
29.0
|
|
|
27.8
|
|
|
27.5
|
|
|
27.1
|
|
Corporate administrative expenses
|
|
|
(2.5
|
)
|
|
(3.3
|
)
|
|
(2.6
|
)
|
|
(2.7
|
)
|
|
|
|
26.5
|
|
|
24.5
|
|
|
24.9
|
|
|
24.4
|
|
Interest expense
|
|
|
(3.0
|
)
|
|
(2.2
|
)
|
|
(2.9
|
)
|
|
(2.2
|
)
|
Other income/(expense)
|
|
|
-
|
|
|
(0.3
|
)
|
|
-
|
|
|
(0.2
|
)
|
Earnings before income taxes
|
|
|
23.6
|
|
|
22.0
|
|
|
22.0
|
|
|
22.1
|
|
Income taxes
|
|
|
(7.1
|
)
|
|
(6.4
|
)
|
|
(6.1
|
)
|
|
(6.5
|
)
|
Net earnings
|
|
|
16.5
|
%
|
|
15.6
|
%
|
|
15.9
|
%
|
|
15.6
|
%
|
|
|
Net orders booked for the
three months ended September 30, |
|
Order backlog as of September 30,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
Industrial Technology
|
|
$
|
197,549
|
|
$
|
191,955
|
|
$
|
131,768
|
|
$
|
143,808
|
|
Energy Systems & Controls
|
|
|
148,922
|
|
|
147,304
|
|
|
120,415
|
|
|
118,510
|
|
Medical & Scientific Imaging
|
|
|
262,320
|
|
|
177,528
|
|
|
276,926
|
|
|
243,749
|
|
RF Technology
|
|
|
229,484
|
|
|
202,959
|
|
|
515,683
|
|
|
472,342
|
|
|
|
$
|
838,275
|
|
$
|
719,746
|
|
$
|
1,044,792
|
|
$
|
978,409
|
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
Cash provided by/(used in):
|
||||||||||||||||
Operating activities
|
$
|
255.8
|
$
|
205.4
|
$
|
566.8
|
$
|
466.2
|
||||||||
Investing activities
|
(18.6
|
)
|
(1,417.3
|
)
|
(1,046.7
|
)
|
(1,474.1
|
)
|
||||||||
Financing activities
|
(161.4
|
)
|
1,039.6
|
569.5
|
1,020.0
|
$400 million senior notes due 2017
|
$
|
400,000
|
||
$800 million senior notes due 2018
|
800,000
|
|||
$500 million senior notes due 2019
|
500,000
|
|||
$500 million senior notes due 2022
|
500,000
|
|||
Senior Subordinated Convertible Notes
|
9,770
|
|||
Revolving Facility
|
390,000
|
|||
Other
|
6,087
|
|||
Total debt
|
2,605,857
|
|||
Less current portion
|
12,250
|
|||
Long-term debt
|
$
|
2,593,607
|
|
|
September 30,
2013 |
|
|
December 31,
2012
|
|||
Total debt
|
|
$
|
2,605,857
|
|
|
$
|
2,022,122
|
|
Cash
|
|
|
(459,980
|
)
|
|
|
(370,590
|
)
|
Net debt
|
|
|
2,145,877
|
|
|
|
1,651,532
|
|
Stockholders' equity
|
|
|
4,062,813
|
|
|
|
3,687,726
|
|
Total net capital
|
|
$
|
6,208,690
|
|
|
$
|
5,339,258
|
|
|
|
|
|
|
|
|
|
|
Net debt / Total net capital
|
|
|
34.6
|
%
|
|
|
30.9
|
%
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|
/s/ Brian D. Jellison
|
|
Chairman of the Board, President,
|
November 8, 2013
|
Brian D. Jellison
|
|
and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
/s/ John Humphrey
|
|
Chief Financial Officer and
|
November 8, 2013
|
John Humphrey
|
|
Executive Vice President
|
|
|
|
(Principal Financial Officer)
|
|
/s/ Paul J. Soni
|
|
Vice President and Controller
|
November 8, 2013
|
Paul J. Soni
|
|
(Principal Accounting Officer)
|
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|